中国药业
中國藥業
중국약업
CHINA PHARMACEUTICALS
2014年
16期
114-115
,共2页
依诺沙星%湿毒清胶囊%膀胱壁瓣输尿管成形术%输尿管下段损伤
依諾沙星%濕毒清膠囊%膀胱壁瓣輸尿管成形術%輸尿管下段損傷
의낙사성%습독청효낭%방광벽판수뇨관성형술%수뇨관하단손상
enoxacin%Shiduqing Capsule%bladder wall flap ureteroplasty%lower ureteral injury
目的：研究依诺沙星联合湿毒清胶囊预防膀胱壁瓣输尿管成形术术后感染的临床疗效。方法随机抽取2010年1月到2013年10月医院收治的输尿管下段损伤患者80例，随机分为对照组和观察组，各40例。所有患者采用经膀胱壁瓣输尿管成形术治疗治疗输尿管下段损伤，对照组患者在术中和术后采用依诺沙星预防感染，观察组患者在术前和术后排气后加用湿毒清胶囊。治疗结束后，观察临床疗效，统计并发症、疼痛以及感染的的发生情况。结果观察组总有效率为92.50%，对照组为90.00%，两组无显著性差异（ P >0.05）。观察组共有6例患者在治疗后出现了感染等并发症，对照组共发生15例，两组并发症总发生率有统计学差异（ P <0.05）；观察组患者各时点疼痛评分均低于对照组，差异有统计学意义（ P <0.05）；两组患者均未发生严重不良反应。结论膀胱壁瓣输尿管成形术治疗输尿管下段损伤临床疗效好，应用依诺沙星联合湿毒清胶囊的患者感染等术后并发症少，疼痛较轻，值得推广。
目的：研究依諾沙星聯閤濕毒清膠囊預防膀胱壁瓣輸尿管成形術術後感染的臨床療效。方法隨機抽取2010年1月到2013年10月醫院收治的輸尿管下段損傷患者80例，隨機分為對照組和觀察組，各40例。所有患者採用經膀胱壁瓣輸尿管成形術治療治療輸尿管下段損傷，對照組患者在術中和術後採用依諾沙星預防感染，觀察組患者在術前和術後排氣後加用濕毒清膠囊。治療結束後，觀察臨床療效，統計併髮癥、疼痛以及感染的的髮生情況。結果觀察組總有效率為92.50%，對照組為90.00%，兩組無顯著性差異（ P >0.05）。觀察組共有6例患者在治療後齣現瞭感染等併髮癥，對照組共髮生15例，兩組併髮癥總髮生率有統計學差異（ P <0.05）；觀察組患者各時點疼痛評分均低于對照組，差異有統計學意義（ P <0.05）；兩組患者均未髮生嚴重不良反應。結論膀胱壁瓣輸尿管成形術治療輸尿管下段損傷臨床療效好，應用依諾沙星聯閤濕毒清膠囊的患者感染等術後併髮癥少，疼痛較輕，值得推廣。
목적：연구의낙사성연합습독청효낭예방방광벽판수뇨관성형술술후감염적림상료효。방법수궤추취2010년1월도2013년10월의원수치적수뇨관하단손상환자80례，수궤분위대조조화관찰조，각40례。소유환자채용경방광벽판수뇨관성형술치료치료수뇨관하단손상，대조조환자재술중화술후채용의낙사성예방감염，관찰조환자재술전화술후배기후가용습독청효낭。치료결속후，관찰림상료효，통계병발증、동통이급감염적적발생정황。결과관찰조총유효솔위92.50%，대조조위90.00%，량조무현저성차이（ P >0.05）。관찰조공유6례환자재치료후출현료감염등병발증，대조조공발생15례，량조병발증총발생솔유통계학차이（ P <0.05）；관찰조환자각시점동통평분균저우대조조，차이유통계학의의（ P <0.05）；량조환자균미발생엄중불량반응。결론방광벽판수뇨관성형술치료수뇨관하단손상림상료효호，응용의낙사성연합습독청효낭적환자감염등술후병발증소，동통교경，치득추엄。
Objective To study the clinical efficacy of enoxacin combined with Shiduqing Capsules for preventing infection after bladder wall flap ureteroplasty. Methods 80 patients with lower ureteral injury treated in our hospital from January 2010 to October 2013 were randomly selected and randomly divided into the control group and the observation group,40 cases in each group. The lower ureteral in-jury in all the cases was treated by bladder wall flap ureteroplasty. The control group adopted intraoperative and postoperative enoxacin for preventing infection,while the observation group was added with Shiduqing Capsule before operation and after postoperative anal ex-haust. The clinical effects after treatment were observed in the two groups. The occurrence situation of complications,pain and infection injury were investigated and statistically analyzed. Results The total effective rate was 92. 50% in the observation group and 90. 00%in the control group without statistically significant difference between the two groups( P > 0. 05);6 cases of postoperative complications such as infection occurred in the observation group and 15 cases in the control group,the total occurrence rate of complications had statistical difference between the two groups( P < 0. 05);the pain score at each timepoint in the observation group was lower than that in the control group with statistical difference between them( P < 0. 05);no serious adverse reactions occurred in the two groups. Conclusion Bladder wall flap ureteroplasty has better effect for treating lower ureteral injury by bladder wall flap ureteroplasty and the combination of enoxacin and Shiduqing Capsules has few complications and slight pain,which deserves to be generalized.
